Ij. Wang et al., THE EFFECT OF INTRAVITREAL INJECTION OF ATROPINE ON THE PROLIFERATIONOF SCLERAL CHONDROCYTE IN-VIVO, Journal of ocular pharmacology and therapeutics, 14(4), 1998, pp. 337-343
Atropine was found to be effective in arresting the progression of myo
pia. However, the actual mechanism is still unclear. Thus, we tried to
investigate the in vivo effect of atropine on the proliferation of sc
leral chondrocytes in chicks of form-deprivation myopia. Twenty chicks
were equally divided into 4 groups which included intravitreal inject
ion of normal saline (IVN), IVN with goggling (IVNG), intravitreal inj
ection of atropine (1%) (IVA), and IVA with goggling (IVAG) groups. In
travenous injection of bromodeoxyuridine (BrdU) (30 mg/kg) from subaxi
llary vein was performed 2 hours before being sacrificed. The eyeballs
were then fixed in 10% neutral-buffered formalin at 4 degrees C. Stan
dard BrdU immunohistochemical staining was performed. The BrdU labelin
g index was obtained from the average of positive labelings of BrdU in
scleral chondrocytes for every 100 counting cells in posterior poles
and anterior scleral margins by two experienced technicians. The BrdU
index on the anterior scleral margin of the NAG group was less than th
at of the IVNG group. The index on the anterior scleral margin of the
IVNG group was higher than the NN group. Although the index on the pos
terior poles of the IVNG group was also higher than the IVN group, it
was statistically not different. Also, no statistical difference was f
ound between IVN and IVA on the anterior scleral margins or posterior
poles. The index was significantly different on the anterior scleral m
argins, but not on the posterior pole among each group. Therefore, int
ravitreal injection of atropine could inhibit the proliferation of cho
ndrocytes on the anterior margins of sclera, but not the posterior pol
es in form-deprivation myopia.